Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| Upstream (Parents) |
|---|
| (<<) SKAP1 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| (<<) LRP1 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| (<<) CAPN3 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| (<<) DLGAP5 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| (<<) NUSAP1 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A |
| Downstream (Children) |
|---|
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → LOC441601 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → SKAP1 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → EXPH5 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → CG012 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → USH2A (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → MAST4 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → POU6F2 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → CC2D1A (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → DLEC1 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → C3orf14 (>>) |
| AMY2B///AMY2A///AMY1C///AMY1B///AMY1A → CACNA2D1 (>>) |
